A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Leon Berard
Hackensack Meridian Health
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Institut Claudius Regaud
Dana-Farber Cancer Institute
Emerald Clinical Inc.
Pfizer
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Actuate Therapeutics Inc.
Stanford University
National Cancer Institute (NCI)
Grupo Espanol de Investigacion en Sarcomas
Organon and Co
Brown University
Brown University
University of Iowa
Sarcoma Alliance for Research through Collaboration
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Stanford University
Assaf-Harofeh Medical Center
Hoffmann-La Roche
Imunon
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Infinity Pharmaceuticals, Inc.
Asan Medical Center
Amgen